Expression and clinical significance of the proliferation marker minichromosome maintenance protein 2 (Mcm2) in diffuse astrocytomas WHO grade II

BACKGROUND: The WHO classification system for astrocytomas is not considered optimal, mainly because of the subjective assessment of the histopathological features. Few prognostic variables have been found that stratify the risk of clinical progression in patients with grade II astrocytoma. For that...

Descripción completa

Detalles Bibliográficos
Autores principales: Lind-Landström, Tove, Varughese, Rosilin K, Sundstrøm, Stein, Torp, Sverre H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3648352/
https://www.ncbi.nlm.nih.gov/pubmed/23618321
http://dx.doi.org/10.1186/1746-1596-8-67

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3648352/
https://www.ncbi.nlm.nih.gov/pubmed/23618321
http://dx.doi.org/10.1186/1746-1596-8-67

Ejemplares similares